BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Bio-PAT - ECPv5.3.2.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Bio-PAT
X-ORIGINAL-URL:https://bio-pat.org
X-WR-CALDESC:Veranstaltungen für Bio-PAT
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20230417T083000
DTEND;TZID=Europe/Paris:20230419T183000
DTSTAMP:20260617T171813
CREATED:20230112T145330Z
LAST-MODIFIED:20230112T150124Z
UID:7215-1681720200-1681929000@bio-pat.org
SUMMARY:KNAUER at the LNP Formulation & Process Development Summit
DESCRIPTION:The Lipid Nanoparticle Formulation & Perocess Development Summit welcomes 350+ LNP Biology\, Chemistry\, Formulation & Process Development\, Tech Ops & Manufacturing experts for sharing\, learning and networking to turbocharge next generation of LNP development. With expanded content\, the 3-tracks summit will now offer the most comprehensive content\, equipping you with end-to-end LNP development journey to exploit this lucrative non-viral delivery vehicle for various payloads to your destined cells and organs. 1. Lipid Chemistry & Discovery Track: Novel lipid discovery and particle engineering to customize LNP composition for next generation LNPs2. Formulation & Process Development Track: Optimise your LNP development techniques for enhanced manufacturability and product quality\, and overcoming stability issues of LNP-nucleic acid drug products3. LNP CMC & Manufacturing Track: Elevating your process control\, CQAs framework for CMC\, GMP compliance for seamless scale-up and achieving GMP compliance \n\n\n\nFurther\, the following topics are covered:– In depth discussions divulging IP and regulatory compliance for LNP drug product– Maximizing LNP’s flexibility and versatility for payloads beyond mRNA vaccines with RNA\, DNA\, gene therapy and gene editing possibilities \n\n\n\nJoin the ever-growing audience of LNP experts seeking to overcome the challenges of developing LNPs for a variety of applications and payloads\, from discovery\, formulation & process development\, lipid supply and scale up manufacturing departments.Hear from likes of Omega Therapeutics\, AstraZeneca\, Pfizer\, Beam Therapeutics\, Alnylam Pharmaceuticals and more. \n\n\n\nKNAUER Wissenschaftliche Geräte GmbH\, a member of the network Bio-PAT\, is an Innovation Partner of the event. \n\n\n\nAgenda at a glanceDownload full guideAttendeesRegistration
URL:https://bio-pat.org/event/knauer-at-the-lnp-formulation-process-development-summit
LOCATION:Venue: The Westin Boston Seaport District\, 425 Summer Street\, Boston\, Massachusetts\, 02210\, Vereinigte Staaten
ATTACH;FMTTYPE=image/jpeg:https://bio-pat.org/wp-content/uploads/2023/01/27708-LNP-Formulation-Process-Development-Summit-logo-2048x517-1.jpg
END:VEVENT
END:VCALENDAR